Press Release
Category Added in a WPeMatico Campaign
-
U.S. FDA Approves TECVAYLI® in Combination with DARZALEX FASPRO® for Relapsed/Refractory Multiple Myeloma
FDA approval based on Phase 3 data demonstrating statistically significant improvements in progression‑free survival and overall survival versus standard of…
Read More » -
DiligenceSquared Raises $5M to Bring AI-Driven Commercial Due Diligence to Private Equity
New AI-native platform conducts expert interviews, synthesizes findings, and delivers fully traceable diligence reports traditionally produced by consulting firms NEW…
Read More » -
Enhans Launches Global Agentic AI Campaign with Lee Sedol in New York Times Square
Large-scale outdoor advertising to run across New York Times Square, Toronto, and Tokyo Shibuya SAN FRANCISCO, March 6, 2026 /PRNewswire/…
Read More » -
Intensity Therapeutics Regains Compliance with Nasdaq’s Minimum Bid Price Requirement
SHELTON, Conn., March 6, 2026 /PRNewswire/ — Intensity Therapeutics, Inc. (“Intensity” or “the Company”) (Nasdaq: INTS), a late-stage clinical biotechnology…
Read More »